All C. jejuni isolates were cases from the University of California (UC) Davis California Animal Health and Food Safety Laboratory System (CAHFS) and sequenced by the 100K Pathogen Genome Project (http://www.100kgenomes.org) in the laboratory of Bart Weimer (UC Davis, Davis, CA). As described (16), isolates were checked for purity (17) , genomic DNA (gDNA) was extracted from cultures grown on 5% blood agar plates (UC Davis, VetMed Biological Services) for 1 to 2 days, lysed (18) , purified with Qiagen QIAamp DNA minikit, and analyzed on Agilent 2200 TapeStation system using the Genomic DNA ScreenTape assay for integrity of gDNA (19) . Isolated gDNA was used to construct libraries using the Kapa HyperPlus kit (KR1145 version 3.16; Kapa Biosystems, Wilmington, MA, USA) with dual-SPRI size selection (20) . Libraries were constructed using the PerkinElmer Sciclone next-generation sequencing (NGS) Workstation (PerkinElmer, Hopkinton, MA). Library quantitation was done using the Kapa SYBR Fast quantitative PCR (qPCR) kits (Kapa Biosystems) to ensure the starting concentration of 400 ng and a fragment insert size between 350 and 450 bp (20) . Libraries were indexed using Integrated DNA Technologies Weimer 384 TS-LT DNA barcodes, which allowed multiplexing up to 384 isolates. Sequencing was done at the UC Davis Genome Center (Davis, CA, USA) on the HiSeq 3000 instrument using a paired-end 150 protocol (Illumina, Inc., San Diego, CA, USA) (21, 22) . Paired-end reads were assembled using ABySS 1.5.2 using k ϭ 64 (23) . Accession number(s). These sequences can be found in the 100K Project BioProject at the NCBI SRA BioProject PRJNA186441 and in the NCBI GenBank. Individual GenBank and SRA accession numbers are presented in Table 1 .
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